{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:11:21Z","timestamp":1790122281227,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00296-017-3920-1","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T10:50:19Z","timestamp":1514976619000},"page":"425-432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5418-6486","authenticated-orcid":false,"given":"Ole Rintek","family":"Madsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"3920_CR1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.berh.2007.02.010","volume":"21","author":"J Zochling","year":"2007","unstructured":"Zochling J, Braun J (2007) Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol 21:699\u2013712","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3920_CR2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0889-857X(05)70043-0","volume":"24","author":"MM Ward","year":"1998","unstructured":"Ward MM (1998) Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 24:815\u2013827","journal-title":"Rheum Dis Clin North Am"},{"key":"3920_CR3","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3899\/jrheum.150463","volume":"42","author":"M Bedaiwi","year":"2015","unstructured":"Bedaiwi M, Sari I, Thavaneswaran A, Ayearst R, Haroon N, Inman RD (2015) Fatigue in ankylosing spondylitis and nonradiographic axial spondyloarthritis: analysis from a longitudinal observation cohort. J Rheumatol 42:2354\u20132360","journal-title":"J Rheumatol"},{"key":"3920_CR4","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to evaluate to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"3920_CR5","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"3920_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/35.1.66","volume":"35","author":"SD Jones","year":"1996","unstructured":"Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath ankylosing spondylitis patient global score (BAS-G). Br J Rheumatol 35:66\u201371","journal-title":"Br J Rheumatol"},{"key":"3920_CR7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","volume":"70","author":"D Heijde Van der","year":"2011","unstructured":"Van der Heijde D, Sieper J, Maksymowych WP, Dougados M, Burgos-Vargas R, Landew\u00e9 R et al (2011) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70:905\u2013908","journal-title":"Ann Rheum Dis"},{"key":"3920_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11926-015-0522-3","volume":"17","author":"R Landew\u00e9","year":"2015","unstructured":"Landew\u00e9 R, van Tubergen A (2015) Clinical Tools to Assess and Monitor Spondyloarthritis. Curr Rheumatol Rep 17:47","journal-title":"Curr Rheumatol Rep"},{"key":"3920_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.20910","volume":"53","author":"H Dagfinrud","year":"2005","unstructured":"Dagfinrud H, Vollestad NK, Loge JH, Kvien TK, Mengshoel AM (2005) Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures. Arthritis Rheum 53:5\u201311","journal-title":"Arthritis Rheum"},{"key":"3920_CR10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00296-007-0313-x","volume":"27","author":"Y Turan","year":"2007","unstructured":"Turan Y, Duru\u00f6z MT, Bal S, Guvenc A, Cerrahoglu L, Gurgan A (2007) Assessment of fatigue in patients with ankylosing spondylitis. Rheumatol Int 27:847\u2013852","journal-title":"Rheumatol Int"},{"key":"3920_CR11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10067-009-1204-1","volume":"28","author":"R G\u00fcnaydin","year":"2009","unstructured":"G\u00fcnaydin R, G\u00f6ksel Karatepe A, Cesmeli N, Kaya T (2009) Fatigue in patients with ankylosing spondylitis: relationships with disease-specific variables, depression and sleep disturbance. Clin Rheumatol 28:1045\u20131051","journal-title":"Clin Rheumatol"},{"key":"3920_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/art1.10179","volume":"47","author":"A Tubergen van","year":"2002","unstructured":"van Tubergen A, Coenen J, Landew\u00e9 R, Spoorenberg A, Chorus A, Boonen A et al (2002) Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Rheum 47:8\u201316","journal-title":"Arthritis Rheum"},{"key":"3920_CR13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.62.9.817","volume":"62","author":"J Braun","year":"2003","unstructured":"Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M et al (2003) International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62:817\u2013824","journal-title":"Ann Rheum Dis"},{"key":"3920_CR14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10067-010-1407-5","volume":"29","author":"OR Madsen","year":"2010","unstructured":"Madsen OR, Rytter A, Hansen LB, Suetta C, Egsmose C (2010) Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients. Clin Rheumatol 29:849\u2013854","journal-title":"Clin Rheumatol"},{"key":"3920_CR15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/bmj.313.7059.744","volume":"313","author":"JM Bland","year":"1996","unstructured":"Bland JM, Altman DG (1996) Measurement error. BMJ 313:744","journal-title":"BMJ"},{"key":"3920_CR16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/00365519709168313","volume":"227","author":"E Magid","year":"1997","unstructured":"Magid E (1997) Minimal requirements for test evaluation. Scand J Clin Lab Invest Suppl 227:90\u201394","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"3920_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/030097499750042272","volume":"111","author":"H Cronstedt","year":"1999","unstructured":"Cronstedt H, Waldner A, Stenstr\u00f6m CH (1999) The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity. Scand J Rheumatol Suppl 111:1\u20139","journal-title":"Scand J Rheumatol Suppl"},{"key":"3920_CR18","first-page":"199","volume":"42","author":"G Udrea","year":"2004","unstructured":"Udrea G, Ciobanu C, Mihai C, Stoica V, Suteanu S, van der Heijde D et al (2004) Evaluation of the Romanian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) in patients with spondyloarthropathies. Rom J Intern Med 42:199\u2013209","journal-title":"Rom J Intern Med"},{"key":"3920_CR19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00296-004-0481-x","volume":"25","author":"AG Karatepe","year":"2005","unstructured":"Karatepe AG, Akkoc Y, Akar S, Kirazli Y, Akkoc N (2005) The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity. Rheumatol Int 25:612\u2013618","journal-title":"Rheumatol Int"},{"key":"3920_CR20","first-page":"571","volume":"25","author":"D Chatzitheodorou","year":"2007","unstructured":"Chatzitheodorou D, Kabitsis C, Papadopoulos NG, Galanopoulou V (2007) Evaluation of the Greek version of the Bath Ankylosing Spondylitis Functional Index: reliability, validity, and factor analysis. Clin Exp Rheumatol 25:571\u2013576","journal-title":"Clin Exp Rheumatol"},{"key":"3920_CR21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10067-007-0755-2","volume":"27","author":"Y Miedany El","year":"2008","unstructured":"El Miedany Y, Youssef S, Mehenna A (2008) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global Score (BASG). Clin Rheumatol 27:605\u2013612","journal-title":"Clin Rheumatol"},{"key":"3920_CR22","first-page":"451","volume":"21","author":"MH Cardiel","year":"2003","unstructured":"Cardiel MH, Londono JD, Gutierrez E, Pacheco-Tena C, V\u00e1zquez-Mellado J, Burgos-Vargas R (2003) Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 21:451\u2013458","journal-title":"Clin Exp Rheumatol"},{"key":"3920_CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/PL00011179","volume":"19","author":"S Heikkila","year":"2000","unstructured":"Heikkila S, Viitanen JV, Kautianen H, Kauppi M (2000) Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondyloarthropathy. Clin Rheumatol 19:464\u2013469","journal-title":"Clin Rheumatol"},{"key":"3920_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10067-004-0984-6","volume":"24","author":"HT Ozer","year":"2005","unstructured":"Ozer HT, Sarpel T, Gulek B (2005) The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity. Clin Rheumatol 24:123\u2013128","journal-title":"Clin Rheumatol"},{"key":"3920_CR25","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s10067-007-0573-6","volume":"26","author":"JC Wei","year":"2007","unstructured":"Wei JC, Wong RH, Huang JH, Yu CT, Chou CT, Jan MS et al (2007) Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan. Clin Rheumatol 26:1685\u20131691","journal-title":"Clin Rheumatol"},{"key":"3920_CR26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.27227","volume":"62","author":"ML Hetland","year":"2010","unstructured":"Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT et al (2010) Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab. Arthritis Rheum 62:22\u201332","journal-title":"Arthritis Rheum"},{"key":"3920_CR27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/rheumatology\/keq309","volume":"50","author":"ML Hetland","year":"2011","unstructured":"Hetland ML (2011) DANBIO\u2014powerful research database and electronic patient record. Rheumatology 50:69\u201377","journal-title":"Rheumatology"},{"key":"3920_CR28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/03009740600904268","volume":"36","author":"OB Pedersen","year":"2007","unstructured":"Pedersen OB, Hansen GO, Svendsen AJ, Ejstrup L, Junker P (2007) Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish. Scand J Rheumatol 36:22\u201327","journal-title":"Scand J Rheumatol"},{"key":"3920_CR29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307\u2013310","journal-title":"Lancet"},{"key":"3920_CR30","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/ard.2008.097345","volume":"68","author":"T Uhlig","year":"2009","unstructured":"Uhlig T, Kvien TK, Pincus T (2009) Test\u2013retest reliability of disease activity core set measures and indices in rheumatoid arthritis. Ann Rheum Dis 68:972\u2013975","journal-title":"Ann Rheum Dis"},{"key":"3920_CR31","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10067-013-2300-9","volume":"32","author":"C Heegaard","year":"2013","unstructured":"Heegaard C, Dreyer L, Egsmose C, Madsen OR (2013) Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints. Clin Rheumatol 32:1493\u20131500","journal-title":"Clin Rheumatol"},{"key":"3920_CR32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/bmj.313.7048.41","volume":"313","author":"JM Bland","year":"1996","unstructured":"Bland JM, Altman DG (1996) Measurement error and correlation coefficients. BMJ 313:41\u201342","journal-title":"BMJ"},{"key":"3920_CR33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landew\u00e9 R, Lie E, Kvien TK, Braun J, Baker D et al (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47\u201353","journal-title":"Ann Rheum Dis"},{"key":"3920_CR34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00296-015-3357-3","volume":"36","author":"A Christie","year":"2016","unstructured":"Christie A, Dagfinrud H, Mowinckel P, Hagen KB (2016) Variation in fatigue may be poorly explained by pain: results from a longitudinal, exploratory study. Rheumatol Int 36:279\u2013282","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3920-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3920-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3920-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T05:40:15Z","timestamp":1519191615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3920-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3920"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3920-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,3]]}}}